Cullinan Therapeutics is dedicated to creating new standards of care for patients. 
 
We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class.  

Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.

Biotechnology

Life Sciences

Pharmaceutical

Therapeutics

Cullinan Therapeutics

Cullinan Therapeutics' headquarters in Cambridge, United States

Description

People (13)

Stephen Wax

Mary Kay Fenton

Arialle Weinstein

Yue Zhang

Jeff Jones

Rich Haddaway

Sal Firicano

Jennifer Michaelson

Michael Baranello

Phill Gallacher

David Meek

Todd Shearer

Divya Gupta

Jobs